1 line
3.5 KiB
JSON
1 line
3.5 KiB
JSON
{"Acute myeloid leukaemia": 42.75859542468945, "Acute respiratory distress syndrome": 3.9642173008982144, "Anaemia": 2.310907027196997, "Aspergillus infection": 17.246744755243064, "B-cell lymphoma recurrent": 235.7076294463422, "BK virus infection": 25.8132013532908, "Bacteraemia": 11.825149944179778, "Bacterial infection": 9.056731761608964, "Blood lactate dehydrogenase increased": 8.406682324824763, "Bone lesion": 62.60948007864048, "Bronchopulmonary aspergillosis": 16.246830411481817, "Candida infection": 5.469791678663731, "Clostridium difficile colitis": 11.386443904039048, "Colitis": 7.993067130491874, "Cystitis haemorrhagic": 15.226128801722451, "Cytomegalovirus infection": 5.424477503338146, "Cytomegalovirus infection reactivation": 42.78955912100677, "Cytopenia": 24.784157386503143, "Diffuse large B-cell lymphoma": 31.67731317669775, "Diffuse large B-cell lymphoma recurrent": 205.6403978976627, "Diffuse large B-cell lymphoma refractory": 69.82304652318464, "Disease progression": 23.759761268715145, "Disease recurrence": 8.6425599556636, "Enteritis": 33.228963411339805, "Epstein-Barr virus infection reactivation": 30.197945431269453, "Febrile neutropenia": 36.17453827670129, "Fungal infection": 7.795338135475069, "Gastric cancer": 7.934386489609373, "Gastrointestinal toxicity": 20.46131854364733, "Graft versus host disease": 19.98814560118569, "Granulocytopenia": 6.744459938897255, "Haematotoxicity": 91.91135750287236, "Hepatic cyst": 29.015323312332637, "Hepatitis B reactivation": 15.516634258955971, "Hepatitis acute": 6.311460372249967, "Hepatotoxicity": 4.956630564305426, "Hodgkin's disease": 33.858763843380395, "Hodgkin's disease recurrent": 575.0677120621181, "Ill-defined disorder": 4.719764665112564, "Infection": 3.252099430036429, "Intentional product use issue": 3.608205769563999, "JC virus infection": 126.61304747228668, "Kaposi's sarcoma": 40.38646349054193, "Klebsiella bacteraemia": 173.3695267637119, "Lymphoma": 18.73150043133445, "Lymphopenia": 7.681563915256989, "Malignant neoplasm progression": 2.3766976935474866, "Mantle cell lymphoma recurrent": 533.6099424136872, "Metastatic lymphoma": 162.38853222426616, "Mucosal inflammation": 34.98697437223768, "Myelodysplastic syndrome": 81.4027984094622, "Myelodysplastic syndrome with excess blasts": 187.05989123202315, "Myelosuppression": 3.967085255369893, "Nephropathy toxic": 4.777767750232702, "Neuropathy peripheral": 2.338452565873178, "Neutropenia": 4.235681698556986, "Neutropenic sepsis": 42.005298328183, "Neutrophil count decreased": 2.2197928452518907, "Non-Hodgkin's lymphoma": 56.93476936728541, "Non-Hodgkin's lymphoma recurrent": 567.372300187744, "Off label use": 4.776783221345876, "Pancytopenia": 10.547358989551524, "Plasma cell myeloma": 2.309216098104557, "Pneumocystis jirovecii pneumonia": 20.318614157098374, "Pneumonia": 2.675826417987213, "Pneumonitis": 8.776898531720585, "Polychromasia": 281.1710476480148, "Post transplant lymphoproliferative disorder": 32.85664997954095, "Product use in unapproved indication": 2.631025605959052, "Progressive multifocal leukoencephalopathy": 35.32857658513915, "Pulmonary toxicity": 8.267271925146948, "Respiratory failure": 2.6019668964575198, "Second primary malignancy": 38.05057265653156, "Sepsis": 4.959299852254206, "Septic shock": 5.833560595534096, "Staphylococcal infection": 3.13841633132439, "Stomatitis": 4.7923938226571625, "Systemic mycosis": 76.24867406233687, "Therapy non-responder": 2.8683689590671784, "Therapy partial responder": 13.8483616178848, "Thrombocytopenia": 7.872387953443818, "Venoocclusive liver disease": 58.05605697475786} |